CODX - コ・ダイアグノスティックス (Co-Diagnostics Inc.)

CODXのニュース

   Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast  2021/08/04 15:30:00 Co-Diagnostics
   Co-Diagnostics Inc Shares Close the Week 38.3% Higher - Weekly Wrap  2021/07/24 09:37:09 Kwhen Finance
Co-Diagnostics Inc (CODX) shares closed this week 38.3% higher than it did at the end of last week. The stock is currently up 13.3% year-to-date, down 50.4% over the past 12 months, and up 81.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 rose 0.2%. Trading Activity Shares traded as high as $11.20 and as low as $7.69 this week.Shares closed 70.6% below its 52-week high and 30.1% above its 52-week low.Trading volume this week was 341.6% higher than the 10-day average and 778.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 1.2% higher than its 5-day moving average, 8.6% higher than its 20-day moving average, and 2.2% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -67.8% The company's stock price performance over the past 12 months lags the peer average by -218.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.7% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Co-Diagnostics gets Republic of Korea patent for its CoPrimer technology  2021/07/22 14:27:15 Seeking Alpha
   Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer Patent  2021/07/22 13:30:00 Co-Diagnostics
   Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security  2021/06/18 17:36:00 Intrado Digital Media
New York , June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
   Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast  2021/08/04 15:30:00 Co-Diagnostics
   Co-Diagnostics Inc Shares Close the Week 38.3% Higher - Weekly Wrap  2021/07/24 09:37:09 Kwhen Finance
Co-Diagnostics Inc (CODX) shares closed this week 38.3% higher than it did at the end of last week. The stock is currently up 13.3% year-to-date, down 50.4% over the past 12 months, and up 81.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 rose 0.2%. Trading Activity Shares traded as high as $11.20 and as low as $7.69 this week.Shares closed 70.6% below its 52-week high and 30.1% above its 52-week low.Trading volume this week was 341.6% higher than the 10-day average and 778.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 1.2% higher than its 5-day moving average, 8.6% higher than its 20-day moving average, and 2.2% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -67.8% The company's stock price performance over the past 12 months lags the peer average by -218.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.7% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Co-Diagnostics gets Republic of Korea patent for its CoPrimer technology  2021/07/22 14:27:15 Seeking Alpha
   Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer Patent  2021/07/22 13:30:00 Co-Diagnostics
   Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security  2021/06/18 17:36:00 Intrado Digital Media
New York , June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
   Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security  2021/06/18 17:36:00 Intrado Digital Media
New York , June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
   How The Salt Lake Tribune investigated the connection between the SEC and Co-Diagnostics  2021/06/18 17:12:46 The Salt Lake Tribune
The Salt Lake Tribune needs the public''s financial donations to continue producing quality investigative work.
   Co-Diagnostics, Inc. (CODX) Fell Out Of Favor With Hedge Funds  2021/06/18 16:11:37 Insider Monkey
   Regulatory actions for June 18, 2021  2021/06/18 16:00:00 BioWorld
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Co-Diagnostics, Hecin, Holista Colltech.
   Co-Diagnostics gets CE marking for direct saliva SARS-CoV-2 test  2021/06/18 14:42:09 Seeking Alpha

calendar